[1] 李波,
朱维良, 陈凯先.
小檗碱及其衍生物的研究进展[J]. 药学学报, 2008, 43 (8):773-787.
[2] 林媛,
司书毅, 蒋建东.
小檗碱的抗菌作用[J]. 药学学报, 2018, 53(2):163-168.
[3] Kong W, Wei J, Abidi P, et al. Berberine is a
novel cholesterol lowering drug working through a unique mechanism distinct
from statins[J]. Nat Med, 2004, 10(12): 1344-1351.
[4] Zhang Z, Zhang H, Li B, et al. Berberine
activates thermogenesis in white and brown adipose tissue[J]. Nat Commun, 2014,
5:5493.
[5] Zhang Q, Xiao X, Feng K, et al. Berberine
moderates glucose and lipid metabolism through multipathway mechanism[J]. Evid
Based Complement Alternat Med, 2011, 2011:924851.
[6] Wu HL, Chuang TY, Al-Hendy A, et al.
Berberine inhibits the proliferation of human uterine leiomyoma cells[J].
Fertil Steril, 2015, 103(4):1098-1106.
[7] Tan W, Li N, Tan, et al. Berberine interfered
with breast cancer cells metabolism,balancing
energy homeostasis[J]. Anti-Cancer Age Med Chem, 2015, 15 (1): 66-78.
[8] Hao X, Yao A, Gong J, et al. Berberine
ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in
human intestinal epithelial cells in vitro[J].
Inflammation, 2012, 35(3): 841-849.
[9] Hu J, Chai Y, Wang Y, et al. PI3K p55γ promoter activity enhancement is
involved in the anti-apoptotic effect of berberine against cerebral ischemia-reperfusion[J].
Eur J Pharmacol, 2012, 674 (2 /3): 132142.
[10]
王雪超,
杜美容. 盐酸小檗碱溶解度与相分配系数研究[J]. 河北北方学院学报 (自然科学版),
2011,1(27): 26-29.
[11] 林媛,
张红娟, 韩燕星,等.小檗碱对肠道菌的抑制作用[J]. 中国医药生物技术, 2018, 4(13): 335-338.
[12] Cui HX, Hu YN, Li JW, et al. Preparation and
Evaluation of Antidiabetic Agents of Berberine Organic Acid Salts for Enhancing
the Bioavailability[J]. Molecules, 2018, 24(1):103.
[13] Lu Q, Dun J, Chen JM, et al. Improving solid-state
properties of berberine chloride through forming a salt cocrystal with citric
acid[J]. Int J Pharm, 2019, 554:14-20.
[14] 刘书妤,
卢琪. 盐酸小檗碱与乳酸共晶、其制备方法和应用[S]. CN 109400598 A.2019-03-01.
[15] Yang D, Cao J, Jiao L, et al. Solubility and
Stability Advantages of a New Cocrystal of Berberine Chloride with Fumaric Acid[J].
ACS Omega, 2020, 5(14):8283-8292.
[16] Wang L, Liu S, Chen JM, et al. Novel Salt-Cocrystals
of Berberine Hydrochloride with Aliphatic Dicarboxylic Acids: Odd-Even
Alternation in Physicochemical Properties[J]. Mol Pharm, 2021, 18(4):1758-1767.
[17] Deng Y, Zhang Y, Huang Y, et al. Preparation,
Crystal Structures, and Oral Bioavailability of Two Cocrystals of Emodin with
Berberine Chloride[J]. Cryst Growth Des, 2018, 18(12):7481-7488.
[18] Sa R, Zhang Y, Deng Y, et al. Novel Salt
Cocrystal of Chrysin with Berberine: Preparation, Characterization, and Oral
Bioavailability[J]. Cryst Growth Des, 2018,18
(8): 4724-4730.
[19] Zhang YJ, Lou BY, Huang YL, et al. Crystal
structure, stability and dissolution of a drug-drug molecular salt hydrate of
berberine with protocatechuic acid[J]. Chinese J Struc Chem, 2018, 37(3): 400-406.
[20] Li P, Ramaiah T, Zhang M, et al. Two
Cocrystals of Berberine Chloride with Myricetin and Dihydromyricetin: Crystal
Structures, Characterization, and Antitumor Activities[J]. Cryst Growth Des, 2020,
20(1): 157-166.
[21] Guan X, Jiang L, Cai L, et al. A New Co-Crystal
of Synthetic Drug Rosiglitazone with Natural Medicine Berberine: Preparation, Crystal
Structures, and Dissolution[J]. Molecules, 2020, 25(18):4288.
[22] He A, Kang X, Xu Y, et al. Investigation on
intermolecular interaction between berberine and β-cyclodextrin
by 2D UV-Vis asynchronous spectra[J]. Spectrochim Acta A Mol Biomo Spectrosc, 2017,
185:343-348.
[23] Zhang Y, Cui YL, Gao LN, et al. Effects of β-cyclodextrin on the intestinal
absorption of berberine hydrochloride, a P-glycoprotein substrate[J]. Int J
Biol Macromol, 2013, 59:363-371.
[24] Huang L, Chen X, Nguyen TX, et al. Nano-cellulose
3D-networks as controlled-release drug carriers[J]. J Mater Chem B, 2013,1(23):2976-2984.
[25] Xiao L, Poudel AJ, Huang L, et al.
Nanocellulose hyperfine network achieves sustained release of berberine
hydrochloride solubilized with β-cyclodextrin for potential anti-infection oral
administration[J]. Int J Biol Macromol, 2020, 153:633-640.
[26] Ma S, Wang Y, Shang X, et al. Formulation of
Berberine Hydrochloride and Hydroxypropyl-β-Cyclodextrin Inclusion Complex with
Enhanced Dissolution and Reduced Bitterness[J]. Trop J Pharm Res, 2012, 11 (6):
871-877.
[27] Wang QS, Li K, Gao LN, et al. Intranasal
delivery of berberine via in situ thermoresponsive hydrogels with non-invasive
therapy exhibits better antidepressant-like effects[J]. Biomater Sci, 2020, 8(10):2853-2865.
[28] Sahibzada MUK, Sadiq A, Faidah HS, et al.
Berberine nanoparticles with enhanced in vitro bioavailability: characterization
and antimicrobial activity[J]. Drug Des Devel Ther, 2018,12:303-312.
[29] Wang Z, Wu J, Zhou Q, et al. Berberine
nanosuspension enhances hypoglycemic efficacy on streptozotocin induced
diabetic C57BL/6 mice [J]. Evid Based Complement Alternat Med, 2015:239749.
[30] Xu H, Yuan XD, Shen BD, et al. Development of
poly(N-isopropylacrylamide) /alginate copolymer hydrogel-grafted fabrics
embedding of berberine nanosuspension for the infected wound treatment[J]. J
Biomater Appl, 2014, 28(9):1376-1385.
[31] Xie YY, Zhang YW, Liu XZ, et al. Aggregation-Induced
Emission-Active Amino acid/Berberine Hydrogels with Enhanced Photodynamic
Antibacterial and Anti-biofilm Activity[J]. Chemical Engineering Journal, 2021,413:127542.
[32] Freag MS, Torky AS, Nasra MM, et al. Liquid
crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate
complex for psoriasis management[J]. Nanomedicine, 2019,14(8):931-954.
[33] Al-Awady MJ, Fauchet A, Greenway GM, et al.
Enhanced antimicrobial effect of berberine in nanogel carriers with cationic
surface functionality[J]. J Mater Chem B, 2017, 5(38):7885-7897.
[34] Amato G, Grimaudo MA, Alvarez-Lorenzo C, et
al. Hyaluronan/Poly-L-lysine/Berberine Nanogels for Impaired Wound Healing[J], Pharmaceutics,2020, 13(1):34.
[35] Zhang P, He L, Zhang J, et al. Preparation of
novel berberine nano-colloids for improving wound healing of diabetic rats by
acting Sirt1/NF-κB pathway[J]. Colloids Surf B Biointerfaces, 2020, 187:110647.
[36] Duong TT, Isom?ki
A, Paaver U, et al. Nanoformulation and Evaluation of Oral Berberine-Loaded
Liposomes[J]. Molecules, 2021, 26(9):2591.
[37] Zhou W, An X, Wang J, et al. Characteristics,
phase behavior and control release for copolymer–liposome
with both pH and temperature sensitivities [J]. Colloid Surface A, 2012, 395: 225-232.
[38] Li J, Hao L, Zhang X, et al. Using Magnetic
and Photic Stimuli-Responsive Liposomes to Serve Up Chemotherapy Drugs to
Cancer Cells[J]. J Biomed Nanotechnol, 2020, 16(6):867-875.
[39] Calvo A, Moreno E, Larrea E, et al. Berberine-Loaded
Liposomes for the Treatment of Leishmania infantum-Infected BALB/c Mice[J].
Pharmaceutics, 2020, 12(9):858.
[40] Wang X, Wang Q, Liu Z, et al. Preparation,
pharmacokinetics and tumour-suppressive activity of berberine liposomes[J]. J
Pharm Pharmacol, 2017, 69(6):625-632.
[41] Lin YH, Lin JH, Chou SC, et al. Berberine-loaded
targeted nanoparticles as specific Helicobacter pylori eradication therapy: in
vitro and in vivo study[J]. Nanomedicine (Lond), 2015, 10(1):57-71.
[42] Yu M, Jambhrunkar S, Thorn P, et al.
Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug
delivery to CD44-overexpressing cancer cells[J]. Nano, 2013, 5(1): 178,183.
[43] Lee T, Lim E-K, Lee J, et al. Efficient CD44-targeted
magnetic resonance imaging (MRI) of breast cancer cells using hyaluronic acid
(HA)-modified MnFe2O4 nanocrystals[J]. Nanoscale Res Lett, 2013, 8(1):149.
[44] Bhatnagar P, Kumari M, Pahuja R, et al.
Hyaluronic acid-grafted PLGA nanoparticles for the sustained delivery of
berberine chloride for an efficient suppression of Ehrlich ascites tumors[J].
Drug Deliv Transl Res, 2018, 8(3):565-579.
[45] Sailor GU, Ramani VD, Shah N, et al. Design
of Experiment Approach Based Formulation Optimization of Berberine Loaded Solid
Lipid Nanoparticle for Antihyperlipidemic Activity [J]. Indian J Pharm Sci, 2021,
83(2):204-218.
[46] Ruan C, Liu L, Lu Y, et al. Substance P-modified
human serum albumin nanoparticles loaded with paclitaxel for targeted therapy
of glioma[J]. Acta Pharm Sin B, 2018, 8(1):85-96.
[47] Zhang Y, Wang L, Li G, et al. Berberine-Albumin
Nanoparticles: Preparation, Thermodynamic Study and Evaluation Their Protective
Effects Against Oxidative Stress in Primary Neuronal Cells as a Model of Alzheimer′s Disease[J]. J Biomed
Nanotechnol, 2021, 17(6):1088-1097.
|